這位是長得像呱太的青蛙醫生(科學超電磁砲第一季第10集)
1.此篇為英文翻中文,工具為Google翻譯,再加上人工(我)矯正。(累死我了www)
2.翻譯採用一個段落先英文後中文,並且會以中文句子為主,在對應的英文句子上面畫上淺色底色,不會標註重點句子。
3.以英文官方文件為主。
07/21/2021: Lab Alert: Changes to CDC RT-PCR for SARS-CoV-2 Testing
07/21/2021:實驗室警報:用於SARS-CoV-2測試的疾病管制與預防中心RT-PCR的改變
Audience: Individuals Performing COVID-19 Testing
對象:執行COVID-19測試的人
Level: Laboratory Alert
等級:實驗室警報
After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives.
在2021年12月31日後,疾病管制與預防中心將撤銷向食品藥品監督管理局 (FDA)提出的CDC 2019-新型冠狀病毒(2019-nCoV)實時RT-PCR診斷測試的緊急使用授權(EUA)之要求,該測試於2020年2月首先採用,只用於SARS-CoV-2。疾病管制與預防中心正在為臨床實驗室有足夠的時間去選擇和實施許多FDA授權的替代品之一提供事先通知。
Visit the FDA website for a list of authorized COVID-19 diagnostic methods. For a summary of the performance of FDA-authorized molecular methods with an FDA reference panel, visit this page. 訪問FDA的網站獲取經授權的COVID-19診斷方法清單。得到在一份FDA參考測試中的一份FDA授權的分子方法實行摘要,訪問此頁面。
In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test. CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses. Such assays can facilitate continued testing for both influenza and SARS-CoV-2 and can save both time and resources as we head into influenza season. Laboratories and testing sites should validate and verify their selected assay within their facility before beginning clinical testing.
為了準備這個變化,疾病管制與預防中心建議一直使用CDC 2019-nCoV RT-PCR檢測的臨床實驗室和檢測點選擇和開始過渡到另一個FDA授權的COVID-19測試。疾病管制與預防中心鼓勵實驗室考慮採用多種方法,因為可以促進SARS-CoV-2和流感的發現和區別。這種檢測可以促進對流感和SARS-CoV-2的持續檢測,並且可以在我們進入流感季節時節省時間和資源。在開始臨床測試前,實驗室和檢測點應該在其場所內確認和驗證他們選擇的檢測。
Online resources:
線上資源:
If you have any questions, please contact us at LOCS@cdc.gov.
Thank you,
感謝您,
The Laboratory Outreach Communication System
實驗室外展通信系統
Laboratory Outreach Communication System (LOCS) | Division of Laboratory Systems (DLS)
實驗室外展通信系統(LOCS) | 實驗室系統司(DLS)
Center for Surveillance, Epidemiology, and Laboratory Services (CSELS)
Centers for Disease Control and Prevention (CDC)
疾病管制與預防中心(CDC)
Page last reviewed: July 19, 2021
頁面最後審查:2021年7月19日
Content source: Division of Laboratory Systems (DLS)
內容來源:實驗室系統司(DLS)
相關連結:無